Philip Obiedzinski in Rutherford, New Jersey

Medical School: New York College Of Podiatric Medicine
Graduation Year: 1980
The Primary Medical Specialty for Philip Obiedzinski is listed as: Podiatry
Approximate Years of Experience: 44
PAC (PECOS ID)#: 5991828642
NPI #: 1003811019
NPI Created On: 06/16/2005
NPI Last Updated Listed as: 03/08/2011
Primary Taxonomy Code: 213ES0103X
License Number:
25MD00126000
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• AmeriHealth New Jersey
• Blue Cross Blue Shield
• AmeriHealth HMO, Inc.
• Humana
• Oscar Garden State Insurance Corporation
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Removal of single thickened skin growth
2. Removal of 2 to 4 thickened skin growths
3. Trimming of fingernails or toenails
4. Removal of tissue from 1 to 5 finger or toe nails
5. Removal of tissue from 6 or more finger or toe nails
6. Injections of tendon sheath, ligament, or muscle membrane
7. Application of ultrasound to 1 or more areas, each 15 minutes
8. New patient office or other outpatient visit, typically 20 minutes
9. New patient office or other outpatient visit, typically 30 minutes
10. Established patient office or other outpatient visit, typically 10 minutes
11. Established patient office or other outpatient visit, typically 15 minutes
12. Trimming of dystrophic nails, any number
13. Follow-up physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include at least the following: (1) a patient history, (2) a physical examination that includes: (a)
14. Routine foot care by a physician of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include, the local care of superficial wounds (i.e. superficial to muscle and fascia) and at least the following i
15. Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg
16. Injection, triamcinolone acetonide, not otherwise specified, 10 mg